scholarly journals Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

2001 ◽  
Vol 27 (4) ◽  
pp. 397-404 ◽  
Author(s):  
K van Besien ◽  
A Rodriguez ◽  
S Tomany ◽  
A Younes ◽  
M Donato ◽  
...  
Keyword(s):  
Growth Factor ◽  
Phase Ii ◽  
Chemotherapy Regimen ◽  
Phase Ii Study ◽  
Response Rates ◽  
High Dose ◽  
Term Survival ◽  
Long Term Survival ◽  
Limited Impact

scholarly journals IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA

2015 ◽  
Vol 17 (suppl 5) ◽  
pp. v109.1-v109 ◽  
Author(s):  
David A. Reardon ◽  
Annick Desjardins ◽  
James Schuster ◽  
David D. Tran ◽  
Karen L. Fink ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Term Survival ◽  
Long Term Survival ◽  
Randomized Phase Ii

Long-Term Survival in Metastatic Melanoma Patients Treated with Sequential Biochemotherapy: Report of a Phase II Study

2006 ◽  
Vol 24 (5) ◽  
pp. 474-478 ◽  
Author(s):  
B. Neri ◽  
L. Vannozzi ◽  
C. Fulignati ◽  
P. Pantaleo ◽  
D. Pantalone ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Term Survival ◽  
Long Term Survival ◽  
Melanoma Patients

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

Lung Cancer ◽  
2003 ◽  
Vol 39 (1) ◽  
pp. 63-69 ◽  
Author(s):  
Martin Reck ◽  
Urzula Jagos ◽  
Franziska Grunwald ◽  
Eckhard Kaukel ◽  
Gabriele Koschel ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Term Survival ◽  
Long Term Survival
Sign in / Sign up

Export Citation Format

Share Document